药易购：2025年前三季度净利润约-836万元

Company Performance - Yaoyigou reported Q3 performance with revenue of approximately 3.242 billion yuan, a year-on-year increase of 0.21% [1] - The net profit attributable to shareholders was a loss of approximately 8.36 million yuan, with basic earnings per share showing a loss of 0.09 yuan [1] - As of the report, Yaoyigou's market capitalization stands at 2.7 billion yuan [1] Industry Insights - In 2023, China's innovative pharmaceuticals have achieved overseas licensing sales of 80 billion USD [1] - The secondary market for biopharmaceuticals is experiencing a surge, while the primary market is facing challenges in fundraising [1]